|
|
(9 intermediate revisions by 3 users not shown) |
Line 47: |
Line 47: |
| <div class="pt-lg-lg pl-lg-5"> | | <div class="pt-lg-lg pl-lg-5"> |
| | | |
− | <p class="lead text-gray my-4">We were very excited to collaborate with Austin_LASA and exchange ideas, given the similarities in our project. Both of our projects rely on Cas12a-fluorophore-based assays in order to create an assay that will allow early detection of HIV | + | <p class="lead text-gray my-4">We were very excited to collaborate with <a href="https://2018.igem.org/Team:Austin_LASA" target="=_blank"><span style="color:blue">Austin_LASA</span></a>and exchange ideas, given the similarities in our project. Both of our projects rely on Cas12a-fluorophore-based assays in order to create an assay that will allow early detection of HIV |
| in infants (as Austin_LASA is performing) and early detection of cancer-relapse. | | in infants (as Austin_LASA is performing) and early detection of cancer-relapse. |
| </p> | | </p> |
Line 60: |
Line 60: |
| | | |
| <p class="lead text-gray my-4">We have developed our Cas12a assay with the purpose of detecting point mutations and chromosomal rearrangements found in ctDNA as well as the detection of an amplicon that contains an amplified miRNA sequence to target. These processes are | | <p class="lead text-gray my-4">We have developed our Cas12a assay with the purpose of detecting point mutations and chromosomal rearrangements found in ctDNA as well as the detection of an amplicon that contains an amplified miRNA sequence to target. These processes are |
− | explained in detail on our Project Design page. (“LINK”) | + | explained in detail on our Project Design page. |
| </p> | | </p> |
| | | |
Line 71: |
Line 71: |
| | | |
| | | |
− | <p class="lead text-gray my-4">(Inset Schematic of Cas12a Assay) During our project, we spent a long time working with these Cas12a assays and there was a lot of effort that went into the optimization of these assays that came with many trials, in terms of Cas12a pre-incubation | + | <p class="lead text-gray my-4">During our project, we spent a long time working with these Cas12a assays and there was a lot of effort that went into the optimization of these assays that came with many trials, in terms of Cas12a pre-incubation |
| time, activator concentration, DNAse alert concentration, etc. We had a very insightful discussion about our experiences and shared our knowledge and advice on working with such Cas12a assays. Here are the protocols that we shared with the | | time, activator concentration, DNAse alert concentration, etc. We had a very insightful discussion about our experiences and shared our knowledge and advice on working with such Cas12a assays. Here are the protocols that we shared with the |
− | Austin_LASA team, hoping that it would provide useful insights for their Cas12a experiment designs. (“TAB OF PROTOCOLS”) | + | Austin_LASA team, hoping that it would provide useful insights for their Cas12a experiment designs. |
| </p> | | </p> |
| | | |
Line 113: |
Line 113: |
| <div class="pt-lg-lg pl-lg-7"> | | <div class="pt-lg-lg pl-lg-7"> |
| | | |
− | <p class="lead text-gray my-4">We were very happy to get the change to collaborate with the NUS Singapore-Sci iGEM Team ! Our collaboration was based on ethical reflections linked to the project, in particular to the methods used and the social implications. </p> | + | <p class="lead text-gray my-4">We were very happy to get the change to collaborate with the <a href="https://2018.igem.org/Team:NUS_Singapore-Sci" target="=_blank"><span style="color:blue">NUS Singapore-Sci iGEM Team</span></a>. Our collaboration was based on ethical reflections linked to the project, in particular to the methods used and the social implications. </p> |
| <p class="lead text-gray my-4">The NUS Singapore-Sci iGEM Team had created a survey on the myths and misconceptions associated with Synthetic Biology. After sharing this survey with us, we entered a discussion that lead to our team deciding to also create a survey that | | <p class="lead text-gray my-4">The NUS Singapore-Sci iGEM Team had created a survey on the myths and misconceptions associated with Synthetic Biology. After sharing this survey with us, we entered a discussion that lead to our team deciding to also create a survey that |
| aims at capturing the general public opinion concerning our project. After investigating the nature of the components in our project, we followed two approaches: firstly to study the impact of the techniques used in the project as well | | aims at capturing the general public opinion concerning our project. After investigating the nature of the components in our project, we followed two approaches: firstly to study the impact of the techniques used in the project as well |
Line 144: |
Line 144: |
| <div class="col-lg-7 ml-lg-auto"> | | <div class="col-lg-7 ml-lg-auto"> |
| <div class="pt-lg-lg pl-lg-7"> | | <div class="pt-lg-lg pl-lg-7"> |
− | <p class="lead text-gray my-4">We were very excited to get contacted by this year’s XMU iGEM team who are working on their own assay called the Aptamer Based Cell-free Detection system (ABCD system). They are using Cas12a in an ingenuitive way to detect proteins through | + | <p class="lead text-gray my-4">We were very excited to get contacted by this year’s <a href="https://2018.igem.org/Team:XMU-China" target="=_blank"><span style="color:blue">XMU iGEM</span></a>team who are working on their own assay called the Aptamer Based Cell-free Detection system (ABCD system). They are using Cas12a in an ingenuitive way to detect proteins through |
| the intermediary of aptamers. Indeed, aptamers have the capacity of recognizing a specific protein and by doing so will release a ssDNA that will be recognized by Cas12a. Since both of our teams are working on a Cas12a detection using | | the intermediary of aptamers. Indeed, aptamers have the capacity of recognizing a specific protein and by doing so will release a ssDNA that will be recognized by Cas12a. Since both of our teams are working on a Cas12a detection using |
| fluorophore quencher it was natural for us to give them all the knowledge we had gathered over the summer about our Cas12a assay. | | fluorophore quencher it was natural for us to give them all the knowledge we had gathered over the summer about our Cas12a assay. |
Line 174: |
Line 174: |
| <br> | | <br> |
| <div class="col-lg-12"> | | <div class="col-lg-12"> |
− | The collaboration with the Athens team started early in the summer, after members of both teams identified multiple shared attributes between the two projects, namely cell free expression, and diagnostic kit development. Thus, the contact started with | + | The collaboration with the <a href="https://2018.igem.org/Team:Athens" target="=_blank"><span style="color:blue">Athens IGEM</span></a>team started early in the summer, after members of both teams identified multiple shared attributes between the two projects, namely cell free expression, and diagnostic kit development. Thus, the contact started with |
| multiple video conferences over the summer. These conferences discussed iGEM EPFL’s experience with cell free systems optimization, especially with linear DNA expression templates. Moreover, the EPFL team benefited from Athens’ team knowledge | | multiple video conferences over the summer. These conferences discussed iGEM EPFL’s experience with cell free systems optimization, especially with linear DNA expression templates. Moreover, the EPFL team benefited from Athens’ team knowledge |
| and experience with kit design to start the kit design for our diagnostic tool. The collaboration finally materialized with Yannis from iGEM Athens visiting the EPFL team and spending some time with us in the lab. The discussion revolved mainly | | and experience with kit design to start the kit design for our diagnostic tool. The collaboration finally materialized with Yannis from iGEM Athens visiting the EPFL team and spending some time with us in the lab. The discussion revolved mainly |
Line 195: |
Line 195: |
| <div class="col-lg-7 ml-lg-auto"> | | <div class="col-lg-7 ml-lg-auto"> |
| <div class="pt-lg-lg pl-lg-7"> | | <div class="pt-lg-lg pl-lg-7"> |
− | <p class="lead text-gray my-4">We had the privilege of collaborating with Great Bay China, a high School team from Shenzhen. We received numerous tips and good advice about poster design, the flow that iGEM presentations should have as well as information about common | + | <p class="lead text-gray my-4">We had the privilege of collaborating with <a href="https://2018.igem.org/Team:GreatBay_China" target="=_blank"><span style="color:blue">Great Bay China</span></a>, a high School team from Shenzhen. We received numerous tips and good advice about poster design, the flow that iGEM presentations should have as well as information about common |
| pitfalls and how to avoid them. On our side, we were able to help them with identifying backup plans to perform the last step of their transformation chemically, since the enzyme performing this action is unknown to this day. | | pitfalls and how to avoid them. On our side, we were able to help them with identifying backup plans to perform the last step of their transformation chemically, since the enzyme performing this action is unknown to this day. |
| </p> | | </p> |
Line 226: |
Line 226: |
| Here are some of the entries that we had, we were very grateful to all the teams that participated in this photo contest, and we hope that more teams will start to explore the interface between biology and art in the future. | | Here are some of the entries that we had, we were very grateful to all the teams that participated in this photo contest, and we hope that more teams will start to explore the interface between biology and art in the future. |
| </div> | | </div> |
| + | <br> |
| + | |
| + | <div class="row row-grid"> |
| + | <div class="col-lg-3"> |
| + | <center> |
| + | <img src="https://static.igem.org/mediawiki/2018/4/41/T--EPFL--comp_1.jpeg" class="img-fluid rounded" width="1000"> |
| + | <figcaption class="mt-3 text-muted">"TAE is BAE" from iGEM team Lambert</figcaption> |
| + | </center> |
| + | </div> |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/a/ae/T--EPFL--comp_2.jpeg"> |
| + | <figcaption class="mt-3 text-muted">"Morning tip box blues" from iGEM team Lambert</figcaption> |
| + | </div> |
| + | |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/d/d8/T--EPFL--comp_3.jpeg"> |
| + | <figcaption class="mt-3 text-muted">"With arms wide open" from iGEM team ICT-Mumbai</figcaption> |
| + | </div> |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/3/34/T--EPFL--comp_4.jpeg"> |
| + | <figcaption class="mt-3 text-muted">"Beam me up Scotty" from iGEM team ICT-Mumbai</figcaption> |
| + | </div> |
| + | </div> |
| + | <br> |
| + | |
| + | <div class="row row-grid"> |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/6/6b/T--EPFL--comp_5_1.jpeg"> |
| + | <figcaption class="mt-3 text-muted">From iGEM team Queen's Canada</figcaption> |
| + | </div> |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/a/a1/T--EPFL--comp_6.jpeg"> |
| + | <figcaption class="mt-3 text-muted">From iGEM team Queen's Canada</figcaption> |
| + | </div> |
| + | |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/b/b4/T--EPFL--comp_7_1.jpeg"> |
| + | <figcaption class="mt-3 text-muted">From iGEM team Queen's Canada</figcaption> |
| + | </div> |
| + | <div class="col-lg-3"> |
| + | <img class="rounded z-depth-3 img-fluid" src="https://static.igem.org/mediawiki/2018/3/30/T--EPFL--comp_8.jpeg"> |
| + | <figcaption class="mt-3 text-muted">"Abomination" from iGEM team TU Eindhoven</figcaption> |
| + | </div> |
| + | </div> |
| | | |
| </article> | | </article> |